Bioequivalence Evaluation of Two Film-Coated Formulations of Valsartan 160 mg

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This was a randomized, single-blind, two-period, two sequence cross-over study under fasting condition, with a one-week wash-out period, to compare the pharmacokinetic profiles and bioavailability of two formulations (the test and reference) of valsartan 160 mg film-coated caplets.
Epistemonikos ID: 28395e01587befdec0f0769e48361726991d2923
First added on: May 12, 2024